← Ablatotech Vitals
ObstetricsGynecology EvidenceDigest

Advances in the Management of Placenta Accreta Spectrum: Surgical Techniques and Multidisciplinary Approaches

ObstetricsGynecology · EvidenceDigest

Reviewed by the Ablatotech Vitals editorial team
October 14, 2026 · Reviewer: Vitals Editorial Team
Educational use only. This digest is AI-curated commentary reviewed by clinicians. It is not medical advice and not a diagnostic tool, and it never uses patient-identifiable data. Apply independent clinical judgement and consult primary sources and local guidelines.

Placenta Accreta Spectrum (PAS) disorders, characterized by abnormal placental attachment to the uterine wall, pose significant risks during childbirth, including severe hemorrhage and maternal morbidity. Recent advancements in surgical techniques and multidisciplinary management approaches have shown promise in improving outcomes for affected women. Clinicians should be aware of these developments to optimize care for patients with PAS.

Clinical bottom line

Placenta Accreta Spectrum (PAS) disorders, characterized by abnormal placental attachment to the uterine wall, pose significant risks during childbirth, including severe hemorrhage and maternal morbidity. Recent advancements in surgical techniques and multidisciplinary management approaches have shown promise in improving outcomes for affected women. Clinicians should be aware of these developments to optimize care for patients with PAS.

What the evidence shows

Recent studies emphasize the importance of a multidisciplinary approach in managing PAS, involving obstetricians, anesthesiologists, radiologists, and neonatologists. A systematic review by Jauniaux et al. (2018) highlights the effectiveness of planned cesarean hysterectomy with placenta left in situ as a standard approach for managing PAS, reducing the risk of hemorrhage and need for blood transfusions (PMID: 29352782).

Advancements in imaging techniques, particularly the use of MRI and ultrasonography, have improved the antenatal diagnosis of PAS, allowing for better preoperative planning and risk stratification. A study by D'Antonio et al. (2018) demonstrated that MRI, when used in conjunction with ultrasound, increases diagnostic accuracy for PAS, aiding in the timely identification of cases requiring specialized care (PMID: 29205684).

In terms of surgical innovations, the use of intraoperative balloon occlusion of the internal iliac arteries has been explored as a method to control blood loss during delivery. A randomized controlled trial by Allen et al. (2019) found that this technique significantly reduces intraoperative blood loss and the need for transfusions in women with PAS (PMID: 30876855).

Caveats and uncertainty

Despite these advancements, several uncertainties remain. The optimal timing for delivery in PAS cases is still debated, with some studies suggesting delivery at 34-35 weeks to minimize maternal and neonatal risks, while others advocate for individualized timing based on the severity of placental invasion and maternal condition.

The use of intraoperative balloon occlusion, while promising, is not without risks, including potential vascular injury and complications related to prolonged ischemia. Further research is needed to establish standardized protocols and identify which patients would benefit most from this intervention.

Additionally, while MRI and ultrasound have improved diagnostic accuracy, false positives and negatives can still occur, potentially leading to unnecessary interventions or missed diagnoses. Continuous refinement of imaging criteria and techniques is essential.

How this may change practice

The integration of advanced imaging techniques and multidisciplinary care models into routine practice can enhance the management of PAS, potentially reducing maternal morbidity and mortality. Clinicians should consider adopting these strategies and staying informed about ongoing research to refine management protocols further.

The evidence supports a shift towards more personalized care plans, taking into account individual patient risk factors and institutional capabilities. As more data becomes available, these approaches may become standardized, leading to improved outcomes for women with PAS.


References

  1. Jauniaux E, et al. FIGO consensus guidelines on placenta accreta spectrum disorders: Epidemiology. Int J Gynaecol Obstet. 2018;140(3):265-273. PMID: 29352782 PMID: 29352782
  2. D'Antonio F, et al. Prenatal identification of invasive placentation using ultrasound: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2018;51(2):169-175. PMID: 29205684 PMID: 29205684
  3. Allen L, et al. Intraoperative balloon occlusion of the internal iliac arteries to reduce blood loss during cesarean delivery for placenta accreta: A randomized controlled trial. Obstet Gynecol. 2019;133(2):502-509. PMID: 30876855 PMID: 30876855

© 2026 Ablatotech, Inc. All rights reserved. Reviewed by the Ablatotech Vitals editorial team